GEF NYSE Week ended 24 Jul 2026

Weekly Investor Report

Greif Bros Corporation · Consumer Cyclical · Packaging & Containers

Open interactive chart View report data
Latest close 78.62 USD
3.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 13.6% above the Trend Line and sits at 99.1% of its 52-week range. The latest completed week returned 3.0%, after a 5.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 39/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high.

Setup score 61 out of 100
Latest Close 78.62 USD 24 Jul 2026
1W Return 3.0% latest completed week
4W Return 5.0% short-term follow-through
12W Return 18.7% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 44.79% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.0% Latest completed week; four-week move 5.0%. Indicator stack 35/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.79% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 39/100 conviction; expected move 8.5%. News sentiment 53/100 51 relevant articles in the latest sentiment read. Event risk 29 Jul Latest stored earnings date was 29 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.6% above the Trend Line and sits at 99.1% of its 52-week range. The latest completed week returned 3.0%, after a 5.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.41

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.0% over four weeks, 18.7% over 12 weeks, and 22.5% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W3.0%
4W5.0%
12W18.7%
26W11.0%
52W22.5%
Active trend streak1 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.89Latest activity-pressure read.
Pressure change1699.1%Four-week change in activity pressure.
Leadership10.52Latest relative-leadership reading.
RS change63.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality19/100Profitability and accounting quality. Underlying universe rank 82; rank 1 is best.
Momentum71/100Medium-term price momentum. Underlying universe rank 30; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework67/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
11.9x
Price divided by trailing earnings.
Price / sales
1.1x
Market value relative to trailing revenue.
EV / EBITDA
6.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
21.7%
Gross profit retained from each unit of revenue.
Operating margin
9.6%
Operating profit retained from revenue.
Free-cash-flow margin
4.5%
Free cash flow generated from revenue.
Return on invested capital
3.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.7%
Latest one-year revenue growth.
EPS growth
-54.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

GEF shows bullish options pressure with a 39/100 conviction score, put-call volume ratio of 0.33, expected move of 8.5%, and Sharemaestro trend signal active.

Conviction39/100
Expected move8.5%
Put/call volume0.33
Pressure40
Speculation8
Volatility59
Trend agreement55
Open options detail
Insider activity2 / 4

2 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 51 relevant articles.

13 positive · 30 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings29 JulLatest stored earnings date was 29 Jul 2026.
Options expected move8.5%Nearest-chain priced movement where available.
52-week drawdown-0.3%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+8.6%Week of 26 Jun.
Worst week-7.9%Week of 15 May.
Latest week+3.0%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains10
Flat weeks0
Modest losses7
Sharp losses4
Recent vol4.0%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis36/100

Latest 12-week confirmation: trend 2/12, activity pressure 5/12, relative leadership 5/12.

Activity pressure 0.57; 2 reversal markers Next-Week ExpectancyNegative 44.79%

Next-week expectancy is negative with a 44.79% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors55/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 64; Small Cap Core rank 26 SVQF67/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 338.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

GEF shows bullish options pressure with a 39/100 conviction score, put-call volume ratio of 0.33, expected move of 8.5%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 8.5% Sentiment53/100

Weighted news tone is neutral across 51 relevant articles.

Wells Fargo & Company Boosts Greif (NYSE:GEF) Price Target to $90.00 Insiders2 / 4

2 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings29 Jul

Latest stored earnings date was 29 Jul 2026.

 Research flow1 items

0 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202678.62 USD3.0%69.24 USD61.21 USD0.8910.521.1MOn
17 Jul 202676.32 USD3.7%68.91 USD61.13 USD0.956.761.2MOff
10 Jul 202673.60 USD-2.1%68.62 USD61.06 USD0.721.37841.1KOff
3 Jul 202675.18 USD0.4%68.39 USD61.01 USD0.564.80832.5KOff
26 Jun 202674.86 USD8.6%68.01 USD60.92 USD0.056.451.4MOff
19 Jun 202668.91 USD1.7%67.65 USD60.84 USD-0.58-4.351.3MOff
12 Jun 202667.79 USD7.5%67.40 USD60.78 USD-0.90-5.241.2MOff
5 Jun 202663.03 USD0.4%67.13 USD60.75 USD-1.16-11.59920.6KOff
29 May 202662.77 USD-1.5%66.93 USD60.76 USD-1.01-14.53885.9KOff
22 May 202663.72 USD2.6%66.68 USD60.71 USD-0.79-12.12912.3KOff
15 May 202662.14 USD-7.9%66.50 USD60.66 USD-0.71-13.66967.4KOff
8 May 202667.47 USD1.9%66.35 USD60.62 USD-0.59-6.21875.1KOn
1 May 202666.24 USD0.5%65.99 USD60.55 USD-0.54-5.801.5MOn
24 Apr 202665.92 USD-4.8%65.75 USD60.49 USD-0.69-5.40924.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.